Recently, Walgreens Boots Alliance (WBA) has announced that it will be acquired by private equity firm Sycamore Partners in a deal valued at $10 billion. Sycamore has agreed to purchase the struggling pharmacy chain for $11.45 per share in cash, with the total transaction value reaching up to $23.7 billion.
The acquisition comes as Walgreens Boots continues to face significant challenges in the post-pandemic retail landscape. The company has been closing stores and attempting a turnaround, but its stock has declined by 49.4% over the past year. WBA, which owns Duane Reade in New York and Boots pharmacies in Britain, has been undergoing a strategic shift, focusing on healthcare services while dealing with mounting financial pressure.
“While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company,” said Walgreens Boots Alliance CEO Tim Wentworth in a statement. “Sycamore will provide us with the expertise and experience of a partner with a strong track record of successful retail turnarounds.”
As part of its restructuring efforts, Walgreens Boots previously announced plans to close approximately 1,200 stores over the next three years, including around 500 closures in fiscal 2025.
The acquisition is expected to be finalized in the fourth quarter of this year. Once the transaction is complete, Walgreens Boots Alliance will be delisted from the Nasdaq Stock Market and transition into a privately held company under Sycamore’s ownership.
